Adolescents who will eventually experiment with marijuana score higher on behaviors of intelligence. Teens who were exposed ...
1don MSN
Companies with cannabis-based drugs eye IPOs, private funding boost after US reclassification
By Puyaan Singh and Christy Santhosh April 30 (Reuters) - Companies developing cannabis-based medicines say U.S. moves to ...
Teen cannabis use is linked to slower cognitive growth, especially memory, with THC as a likely contributor during key ...
Trump administration to reclassify marijuana as Schedule III, easing research barriers but not legalizing the drug or ...
The federal government’s reclassification of medical marijuana products as Schedule III drugs doesn’t federally legalize marijuana, but it might extend tax breaks to some cannabis businesses. The ...
Johns Hopkins research underscores the increased risks of combining cannabis edibles and alcohol—key for public health ...
DOJ moves medical cannabis to Schedule III; biotech firms eye funding and IPOs amid banking and tax uncertainty.
The largest US study to date on teen cannabis uses shows that cannabis use during adolescence may hinder cognitive improvement over time.
Researchers at Johns Hopkins and UC San Diego used artificial intelligence to analyze comments in the public record ...
While recreational cannabis laws have significantly reduced arrests for cannabis possession and sales, racial disparities in ...
Scientists have uncovered a surprising new layer of complexity in Cannabis, identifying dozens of previously unknown compounds—including the first-ever evidence of rare molecules called flavoalkaloids ...
Cannabis stocks often trade less on traditional fundamentals alone and more on changes in policy. Cannabis ETFs are a narrow ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results